Cargando…
Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease
The so-called amyloid hypothesis, that the accumulation and deposition of oligomeric or fibrillar amyloid β (Aβ) peptide is the primary cause of Alzheimer's disease (AD), has been the mainstream concept underlying AD research for over 20 years. However, all attempts to develop Aβ-targeting drug...
Autores principales: | Kametani, Fuyuki, Hasegawa, Masato |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797629/ https://www.ncbi.nlm.nih.gov/pubmed/29440986 http://dx.doi.org/10.3389/fnins.2018.00025 |
Ejemplares similares
-
Can an Infection Hypothesis Explain the Beta Amyloid Hypothesis of Alzheimer’s Disease?
por: Fulop, Tamas, et al.
Publicado: (2018) -
The Beta Amyloid Dysfunction (BAD) Hypothesis for Alzheimer’s Disease
por: Hillen, Heinz
Publicado: (2019) -
Alzheimer’s Disease Biomarkers Revisited From the Amyloid Cascade Hypothesis Standpoint
por: Alawode, Deborah O. T., et al.
Publicado: (2022) -
Senescence as an Amyloid Cascade: The Amyloid Senescence Hypothesis
por: Walton, Chaska C., et al.
Publicado: (2020) -
ACU193: An Immunotherapeutic Poised to Test the Amyloid β Oligomer Hypothesis of Alzheimer’s Disease
por: Krafft, Grant A., et al.
Publicado: (2022)